Supplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer door Sahar Mafi (16721657)

Onderwerpen:

Supplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer door Sahar Mafi (16721657)

Onderwerpen:

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4⁺ T-cell Cluster That Correlates with PD-1 Blockade Efficacy door Hiroshi Kagamu (14961732)

Onderwerpen:

Supplementary File 1 from Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clo... door Huaibin Ge (15047462)

Onderwerpen:

Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S8 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S9 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Table S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Table S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S6 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S2 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S7 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen:

Supplementary Figure S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer door Rohit Thummalapalli (17314483)

Onderwerpen: